Nevada Medicaid

Does Nevada Medicaid cover Zepbound?

Quick answer · Osa

Nevada Medicaid covers Zepbound for osa with prior authorization on Medicaid.

  • Medicaid: Covered with requirements. BMI of 30 or higher

Last verified June 3, 2026. Policy effective April 6, 2026. Source: msm_1200_26_04_06.pdf. How we verify this data →

Check your card for your exact plan →

Zepbound for Osa

What Nevada Medicaid requires, by plan type. Open this indication on its own page →

Medicaid

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • Diagnosed obstructive sleep apnea (AHI of 5 or higher)
  • Not being used to treat type 1 diabetes

Qualification pathways

You can qualify through any one of these.

OSA with obesity - AHI >= 15 (moderate to severe)

All of:

  • Adult age >= 18 years
  • BMI > 30 kg/m2
  • Moderate to severe OSA in adults with obesity
  • 15 or more obstructive respiratory events per hour of sleep confirmed by sleep study from certified or accredited sleep disorder facility
  • No type 1 or type 2 diabetes
  • No contraindications to Zepbound
  • Full compliance with ongoing treatment for underlying airway obstruction (e.g., CPAP, BiPAP) unless provider rationale for why not indicated
  • Provider attestation medication used with reduced calorie diet and increased physical activity

OSA with obesity - AHI >= 5 with symptoms (mild to moderate)

All of:

  • Adult age >= 18 years
  • BMI > 30 kg/m2
  • Moderate to severe OSA in adults with obesity
  • 5 or more obstructive respiratory events per hour of sleep confirmed by sleep study from certified or accredited sleep disorder facility
  • No type 1 or type 2 diabetes
  • No contraindications to Zepbound
  • Full compliance with ongoing treatment for underlying airway obstruction (e.g., CPAP, BiPAP) unless provider rationale for why not indicated
  • Provider attestation medication used with reduced calorie diet and increased physical activity

Plus any one of:

  • Daytime sleepiness
  • Nonrestorative sleep
  • Fatigue
  • Insomnia
  • Waking up with breath holding, gasping, or choking
  • Habitual snoring noted by bed partner or other observer
  • Observed apnea

OSA with obesity - Unable to undergo facility sleep study

All of:

  • Adult age >= 18 years
  • BMI > 30 kg/m2
  • Moderate to severe OSA in adults with obesity
  • Recipient is not an appropriate candidate for a facility sleep study due to immobility, safety, or critical illness
  • Zepbound prescribed by or in consultation with a board-certified sleep specialist or pulmonologist for diagnosis of moderate to severe OSA
  • No type 1 or type 2 diabetes
  • No contraindications to Zepbound
  • Full compliance with ongoing treatment for underlying airway obstruction (e.g., CPAP, BiPAP) unless provider rationale for why not indicated
  • Provider attestation medication used with reduced calorie diet and increased physical activity

Documentation to bring

  • Documentation of BMI > 30 kg/m2
  • Submission of sleep study records confirming OSA from a certified or accredited sleep disorder facility (for pathways 1 and 2), OR documentation that facility sleep study is not appropriate with specialist consultation (pathway 3)
  • Documentation of AHI (obstructive respiratory events per hour of sleep)
  • Documentation of qualifying OSA symptoms if AHI is 5-14 (pathway 2)
  • Board-certified sleep specialist or pulmonologist consultation if facility sleep study not feasible (pathway 3)
  • Confirmation recipient has no type 1 or type 2 diabetes
  • Confirmation of no contraindications to Zepbound
  • Documentation of compliance with CPAP/BiPAP or provider rationale for why PAP therapy is not indicated
  • Provider attestation that medication will be used with reduced calorie diet and increased physical activity

Approval and renewal

  • Initial approval: 6 months
  • Renewal: every 6 months
  • To renew, the plan looks for Documentation of positive clinical response to therapy; recipient continues to be fully compliant with ongoing PAP/BiPAP treatment for underlying airway obstruction (unless provider rationale given why not indicated). T2DM exclusion and BMI requirement not explicitly re-checked at continuation.

Not covered when

  • Type 2 diabetes (this OSA indication is specific to non-diabetic recipients)
  • Any contraindications to Zepbound use
  • Type 1 diabetes

Policy note: osa_ahi_min is set to 5 reflecting the minimum AHI threshold in any qualifying pathway (pathway 2 allows AHI >= 5 with symptoms). Pathway 1 requires AHI >= 15 without additional symptom requirement. PAP therapy (CPAP/BiPAP) compliance is required ongoing but is NOT a prior trial requirement for initial approval — it must be ongoing concurrent treatment. Policy requires submission of records (sleep study records). Recertification at 6 months requires positive clinical response and continued PAP compliance. Both T1DM and T2DM are explicitly excluded — this indication is for non-diabetic patients only.

Policy effective April 6, 2026 · verified June 3, 2026 · source: msm_1200_26_04_06.pdf

Why Zepbound requests get denied by Nevada Medicaid

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Zepbound and Mounjaro are the same molecule with different approved uses; a request for Zepbound under a diagnosis that matches Mounjaro is routinely denied.
  2. BMI not documented in the chart notes (or documented without a baseline weight and date).

Frequently asked questions

Does Nevada Medicaid cover Zepbound?
Nevada Medicaid covers Zepbound for osa with prior authorization on Medicaid.
What BMI do you need for Zepbound under Nevada Medicaid?
For osa on Medicaid plans, Nevada Medicaid requires a BMI of 30 or higher.
How long does a Zepbound approval last with Nevada Medicaid?
Initial approvals last 6 months, and renewals are granted in 6-month periods.
What does Nevada Medicaid require to renew Zepbound?
Documentation of positive clinical response to therapy; recipient continues to be fully compliant with ongoing PAP/BiPAP treatment for underlying airway obstruction (unless provider rationale given why not indicated). T2DM exclusion and BMI requirement not explicitly re-checked at continuation.
How current is this information?
This page reflects Nevada Medicaid's written policy as of April 6, 2026, last verified against the source document on June 3, 2026.

Other medications under Nevada Medicaid

Zepbound coverage under other plans

All insurance plans · All medications

This page summarizes Nevada Medicaid's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.